Pyrazine Derivatives Selective SK Channel Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for diseases associated with potassium channel activity, such as asthma and epilepsy, lack effective modulators for SK channels, which are crucial for regulating cellular functions and are implicated in various disorders.
Innovation Solution
Development of novel pyrazine derivatives that selectively modulate SK1, SK2, and SK3 channels, offering a pharmaceutical solution for treating conditions related to potassium channel activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments are used for diseases associated with potassium channel activity, then existing therapeutic options are available, but effective modulators for SK channels are lacking
Solution Approach 1:
The patent segments the broad category of potassium channels into specific SK channel subtypes (SK1, SK2, SK3) and develops compounds that selectively target each subtype. This segmentation allows for precise modulation of specific channel subtypes rather than acting on all potassium channels generally, thereby achieving both therapeutic effectiveness and channel selectivity.
Solution Approach 2:
The pyrazine derivative compounds exhibit local quality by demonstrating subtype-specific binding characteristics and pharmacological effects on different SK channel subtypes. Each compound formulation is optimized to interact with specific channel subtypes through tailored molecular structures, enabling selective modulation at the level of individual channel subtypes while maintaining therapeutic efficacy.
2Adaptability or versatility
If novel pyrazine derivatives are developed to selectively modulate SK channels, then channel selectivity is improved, but compound complexity increases
Solution Approach 1:
The patent employs parameter changes by systematically modifying molecular parameters of the pyrazine derivative core structure, including substituent types, positions, and configurations. By varying these chemical parameters within a defined structural framework, the invention achieves selective modulation of different SK channel subtypes without requiring fundamentally complex molecular architectures.
Data Source
AI summary
Pyrazine compounds of the formulaas well as stereoisomers thereof, N-oxides thereof, prodrugs thereof, and pharmaceutically acceptable salts thereof, wherein the variables in the formula are as defined in the specification. The compounds are useful as potassium channel modulating agents. Also, pharmaceutical compositions useful for the treatment or alleviation of diseases or disorders associated with the activity of potassium channels, and methods of using the pharmaceutical compositions.